For the Inventor, By the Inventor

Enter assignee name

Glen Rock, NJ, United States of America

Cortex Pharmaceuticals, Inc.

USPTO Granted Patents = 15

% Expired Patents = 40.0

CIPO Patents = 1

EPO Patents = 4

Trademarks = 1

Forward Citations = 216

Loading Chart...

Loading Chart...

18 inventors (with patents filed for the assignee):

Rudolf Mueller (8 out of 11 patents)

Leslie Street (7 out of 9 patents)

Gary A Rogers (5 out of 16 patents)

4. Steven Lee (3 out of 3 patents)

5. Christopher M Marrs (2 out of 5 patents)

6. Gary S Lynch (2 out of 23 patents)

7. David D Eveleth (2 out of 2 patents)

8. Judith A Kelleher (2 out of 2 patents)

9. Carl W Cotman (1 out of 10 patents)

10. Clayton Harris (1 out of 24 patents)

11. Matthew Allan (1 out of 1 patent)

12. Jianjie Huang (1 out of 1 patent)

13. Stanislaw Rachwal (1 out of 1 patent)

14. Steven A Johnson (1 out of 1 patent)

15. David D Eveleth, Jr (1 out of 2 patents)

15 patents: Sort by Forward Citations

1. 8642633 - Di-substituted amides for enhancing glutamatergic synaptic responses (2014-02-04),

2. 8507482 - Bicyclic amide derivatives for enhancing glutamatergic synaptic responses (2013-08-13),

3. 8404682 - Di-substituted amides for enhancing glutamatergic synaptic responses (2013-03-26),

4. 8263591 - Bicyclic amides for enhancing glutamatergic synaptic responses (2012-09-11),

5. 8168632 - Bicyclic amide derivatives for the treatment of respiratory disorders (2012-05-01),

6. 8119632 - Bicyclic amide derivatives for enhancing glutamatergic synaptic responses (2012-02-21),

7. 8013003 - Di-substituted amides for enhancing glutamatergic synaptic responses (2011-09-06),

8. 7799913 - Carbonylbenzoxazine compounds for enhancing glutamatergic synaptic responses (2010-09-21),

9. 6166008 - Treatment of schizophrenia with ampakines and neuroleptics (2000-12-26),

10. 5985871 - Benzoxazine compounds for enhancing synaptic response (1999-11-16),

11. 5736543 - Benzoxazines for enhancing synaptic response (1998-04-07),

12. 5650409 - Benzoyl piperidines/pyrrolidines for enhancing synaptic response (1997-07-22),

13. 5622981 - Use of metabotropic receptor agonists in progressive neurodegenerative (1997-04-22),

14. 5567724 - Alkaline and acid phosphatase inhibitors in treatment of neurological (1996-10-22),

15. 5444042 - Method of treatment of neurodegeneration with calpain inhibitors (1995-08-22),

Cortex Pharmaceuticals, Inc. is a biopharmaceutical company based in Glen Rock, New Jersey, specializing in the development of innovative therapies for neurological disorders. The company focuses on advancing treatments that target cognitive dysfunction and related conditions, leveraging proprietary technologies to enhance drug efficacy. With a commitment to research and development, Cortex aims to address unmet medical needs in the field of neuroscience, contributing to improved patient outcomes and quality of life.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

15 Patents

#1 in Glen Rock, NJ

#801 in New Jersey

#21,034 in US

#39,881 in the World

Glen Rock, NJ, United States of America

Cortex Pharmaceuticals, Inc.

Forward Citations = 216

18 inventors:

Rudolf Mueller (8 out of 11 patents)

Leslie Street (7 out of 9 patents)

Gary A Rogers (5 out of 16 patents)

4. Steven Lee (3 out of 3 patents)

5. Christopher M Marrs (2 out of 5 patents)

Please report any incorrect information to [email protected]

Loading…